3 Rea­sons Why Con­trol­ling Ileitis Through Oral Vac­ci­na­tion Just Makes Sense

Successful Farming - - INSIDER -

Med­i­cated feeds are of­ten thought of as the an­swer to treat­ing pigs in­fected with Law­so­nia

in­tra­cel­lu­laris, the bac­terium that causes ileitis. How­ever, a grow­ing body of re­search demon­strates that tran­si­tion­ing from di­etary an­timi­cro­bials to a vac­ci­na­tion pro­gram can help re­duce the im­pact of ileitis and de­liver im­proved per­for­mance and re­duced costs.1,2,3 The fol­low­ing three points il­lus­trate the ad­van­tages that vac­ci­na­tion with En­ter­isol® Ileitis de­liv­ers:

1. Im­proved per­for­mance A re­cent Fin­nish – study tracked av­er­age daily weight gain of pigs vac­ci­nated with EN­TER­ISOL ILEITIS from the nurs­ery through fin­ish­ing phases. 1 At the end of the nurs­ery phase, vac­ci­nated pigs weighed an av­er­age of 2.65 pounds more than non-vac­ci­nated pigs. At mar­ket, vac­ci­nated pigs weighed an av­er­age of 7.94 pounds more than con­trol group pigs.

2. Vac­cines de­liver ROI In a large-scale field – trial in Korea, nurs­ery pigs vac­ci­nated with EN­TER­ISOL ILEITIS were ob­served to have sig­nif­i­cantly higher ADWG than the con­trol group. That trans­lated to a 4.2:1 re­turn on in­vest­ment from us­ing EN­TER­ISOL ILEITIS, and a $4.80per-pig higher gross mar­gin.2

In ad­di­tion, the cost of a vac­ci­na­tion pro­gram that in­cludes the use of EN­TER­ISOL ILEITIS was ac­tu­ally 50 cents per pig cheaper than a pro­gram in­clud­ing in­jectable an­timi­cro­bials, based on a study of pigs in the fin­ish­ing phase con­ducted by Pipe­stone Vet­eri­nary Clinic. 3

3. Pre­vent rather than treat While – an­timi­cro­bials de­liv­ered in feed can help re­duce the clin­i­cal signs of ileitis, they don’t pro­mote im­mu­nity like a vac­cine does. Vac­ci­na­tion also aligns with the on­go­ing in­dus­try shift away from the use of med­i­cated feeds un­der the Vet­eri­nary Feed Di­rec­tive. EN­TER­ISOL ILEITIS is an ex­cel­lent tool to help pro­duc­ers achieve the con­sumer-driven goal of re­duced an­tibi­otic use. Peipo­nen KS, Birger TT, Jun­nila JJT, Heinonen ML.. Ef­fect of a live at­ten­u­ated vac­cine against Law­so­nia in­tra­cel­lu­laris in weaned and fin­ish­ing-pig set­tings in Fin­land. Acta Vet Scand: 2018;60:18.

Park S, Lee J-B, Kim K-J, et al.Ef­fi­cacy of a com­mer­cial live at­ten­u­ated Law­so­nia in­tra­cel­lu­laris vac­cine in a large scale field trial in Korea. Clin Exp Vac Res: 2013; 2:p135-139. Nerem, J. Law­so­nia in­tra­cel­lu­laris vac­ci­na­tion as an al­ter­na­tive to di­etary an­timi­cro­bial med­i­ca­tion in fin­ish­ing swine. Pre­sented at SafePork con­fer­ence, Que­bec City, Que­bec, Canada. 2009.

En­ter­isol is a reg­is­tered trade­mark of Boehringer In­gel­heim Vetmed­ica GmbH.

©2018 Boehringer In­gel­heim. POR-1083-ENIL0918

Newspapers in English

Newspapers from USA

© PressReader. All rights reserved.